suppose that Anson is selling shares deriving from the exercise of the warrants, in order not to exceed 5 or 10% and thus be able to exercise other warrants: but why not raise the pps and sell at 0.4, for example?
Most of them are concerted exchanges, and is the "collateral damage" that some small shareholder may buy some of these shares considered acceptable?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links